Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 120.2
(-0.5%)
SAR 120.2
(-0.5%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 338.43 Million | 302.66 Million | 287.22 Million | 301.66 Million | 232.09 Million |
| Cost of Revenue | 131.39 Million | 124.98 Million | 117.99 Million | 129.88 Million | 89.15 Million |
| Gross Profit | 207.04 Million | 177.67 Million | 169.22 Million | 171.77 Million | 142.93 Million |
| Operating Expenses | 128.79 Million | 107.33 Million | 92.71 Million | 90.71 Million | 82.59 Million |
| Selling, General and Administrative Expenses | 129.42 Million | 107.33 Million | 92.71 Million | 90.71 Million | 82.59 Million |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | -632.92 Thousand | - | - | - | - |
| Cost and Expenses | 260.19 Million | 232.32 Million | 210.7 Million | 220.6 Million | 171.74 Million |
| Operating Income | 78.24 Million | 70.33 Million | 76.51 Million | 81.05 Million | 60.34 Million |
| Interest Expense | 6.98 Million | 5.83 Million | 2.94 Million | 2.68 Million | 2.31 Million |
| Income Tax Expense | 5.61 Million | 5.57 Million | 4.17 Million | 5 Million | 3.71 Million |
| Earnings before Tax | 71.43 Million | 65.02 Million | 70.45 Million | 77.81 Million | 57.75 Million |
| Net Income | 65.82 Million | 59.45 Million | 66.28 Million | 72.81 Million | 54.05 Million |
| Earnings Per Share Basic | 3.29 | 2.97 | 3.31 | 3.64 | 2.70 |
| Earnings Per Share Diluted | 3.29 | 2.97 | 3.31 | 3.64 | 2.70 |
| Weighted Average Shares Outstanding | 20 Million | 20 Million | 20 Million | 20 Million | 20 Million |
| Weighted Average Shares Outstanding (Diluted) | 20 Million | 20 Million | 20 Million | 20 Million | 20 Million |
| Gross Margin | 0.61 | 0.59 | 0.59 | 0.57 | 0.62 |
| EBIT Margin | 0.25 | 0.27 | 0.30 | 0.30 | 0.30 |
| Profit Margin | 0.19 | 0.20 | 0.23 | 0.24 | 0.23 |
| EBITDA | 85.13 Million | 81.12 Million | 82.97 Million | 89.35 Million | 68.76 Million |
| Earnings Before Tax Margin | 0.23 | 0.23 | 0.27 | 0.27 | 0.26 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 101.13 Million | 75.82 Million | 94.96 Million | 338.43 Million | 94.96 Million | 93.29 Million |
| Cost of Revenue | 36.79 Million | 29.36 Million | 34.45 Million | 138.78 Million | 34.45 Million | 42.55 Million |
| Gross Profit | 64.34 Million | 46.46 Million | 60.5 Million | 199.65 Million | 60.5 Million | 50.73 Million |
| Operating Expenses | 39.82 Million | 34.13 Million | 33.28 Million | 120.97 Million | 33.28 Million | 29.85 Million |
| Selling, General and Administrative Expenses | 39.76 Million | 31.79 Million | 33.32 Million | - | 33.32 Million | 29.85 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -39.82 Million | -34.13 Million | - | - | - | - |
| Cost and Expenses | 76.61 Million | 63.49 Million | 67.74 Million | 259.75 Million | 67.74 Million | 72.41 Million |
| Operating Income | 24.52 Million | 12.33 Million | 27.14 Million | 78.68 Million | 27.14 Million | 20.87 Million |
| Interest Expense | 1.09 Million | - | - | 6.98 Million | - | 1.24 Million |
| Income Tax Expense | 1.62 Million | -9.37 Million | 1.3 Million | 5.61 Million | 1.3 Million | 1.5 Million |
| Earnings before Tax | 23.43 Million | 10.99 Million | 25.44 Million | 71.43 Million | 25.44 Million | 19.54 Million |
| Net Income | 21.8 Million | 9.37 Million | 24.13 Million | 65.82 Million | 24.13 Million | 18.04 Million |
| Earnings Per Share Basic | 1.09 | 0.47 | 1.21 | - | 1.21 | 0.90 |
| Earnings Per Share Diluted | 1.09 | 0.47 | 1.21 | - | 1.21 | 0.90 |
| Weighted Average Shares Outstanding | 20 Million | 20 Million | 20 Million | 20 Million | 20 Million | 20 Million |
| Weighted Average Shares Outstanding (Diluted) | 20 Million | 20 Million | 20 Million | 20 Million | 20 Million | 20 Million |
| Gross Margin | 0.64 | 0.61 | 0.64 | 0.59 | 0.64 | 0.54 |
| EBIT Margin | 0.24 | 0.29 | 0.31 | - | 0.31 | 0.26 |
| Profit Margin | 0.22 | 0.12 | 0.25 | 0.19 | 0.25 | 0.19 |
| EBITDA | 24.52 Million | 21.7 Million | 29.08 Million | - | 29.08 Million | 23.84 Million |
| Earnings Before Tax Margin | 0.24 | 0.16 | 0.29 | 0.23 | 0.29 | 0.22 |
INDIAMART
FCN
PSN
GRINFRA
CYBQF
INMD